Coeptis Therapeutics Cash Flow From Operations vs. Net Asset
| COEPW Stock | USD 0.02 0 19.50% |
For Coeptis Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Coeptis Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Coeptis Therapeutics Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Coeptis Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Coeptis Therapeutics Holdings over time as well as its relative position and ranking within its peers.
Coeptis |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Coeptis Therapeutics. If investors know Coeptis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Coeptis Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets (2.46) | Return On Equity (14.50) |
The market value of Coeptis Therapeutics is measured differently than its book value, which is the value of Coeptis that is recorded on the company's balance sheet. Investors also form their own opinion of Coeptis Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Coeptis Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Coeptis Therapeutics' market value can be influenced by many factors that don't directly affect Coeptis Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Coeptis Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Coeptis Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Coeptis Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Coeptis Therapeutics Net Asset vs. Cash Flow From Operations Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Coeptis Therapeutics's current stock value. Our valuation model uses many indicators to compare Coeptis Therapeutics value to that of its competitors to determine the firm's financial worth. Coeptis Therapeutics Holdings is rated second in cash flow from operations category among its peers. It is rated third in net asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Coeptis Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Coeptis Net Asset vs. Cash Flow From Operations
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Coeptis Therapeutics |
| = | (3.88 M) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Coeptis Therapeutics |
| = | 7.92 M |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Coeptis Net Asset Comparison
Coeptis Therapeutics is currently under evaluation in net asset category among its peers.
Coeptis Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Coeptis Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Coeptis Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Coeptis Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Coeptis Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -30.8 M | -29.2 M | |
| Income Before Tax | -33.8 M | -32.1 M | |
| Total Other Income Expense Net | -3 M | -2.9 M | |
| Net Loss | -33.8 M | -32.1 M | |
| Income Tax Expense | 3.9 M | 4.1 M | |
| Net Interest Income | -136.2 K | -143 K | |
| Net Loss | -20.2 M | -21.2 M | |
| Net Loss | (0.83) | (0.79) | |
| Income Quality | 0.34 | 0.32 | |
| Net Income Per E B T | 0.98 | 0.78 |
Coeptis Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Coeptis Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Coeptis Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Coeptis Therapeutics' important profitability drivers and their relationship over time.
Use Coeptis Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Coeptis Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will appreciate offsetting losses from the drop in the long position's value.Coeptis Therapeutics Pair Trading
Coeptis Therapeutics Holdings Pair Trading Analysis
The ability to find closely correlated positions to Coeptis Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Coeptis Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Coeptis Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Coeptis Therapeutics Holdings to buy it.
The correlation of Coeptis Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Coeptis Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Coeptis Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Coeptis Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Coeptis Therapeutics position
In addition to having Coeptis Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Investing Thematic Idea Now
Investing
Companies involved in money management and investment banking services. The Investing theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.